The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...

A discovery reveals that weight loss drugs like Ozempic and Mounjaro can positively impact 175 diseases and conditions beyond ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

A first-of-its-kind study is taking a look at the benefits of weight loss drugs beyond just losing a few pounds.

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including ...

Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took researchers by surprise.

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

A study by the Department of Veterans Affairs says that drugs like Ozempic can do plenty more than just help with weight loss ...

A new study published in the Nature Medicine monthly journal highlights the benefits and risks of weight-loss drugs like ...

A new study shows that GLP-1 drugs offer health benefits such as reducing risks for heart disease but also carry potential risks like gastrointestinal issues.